Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
2.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
3.

The biology of VEGF and its receptors.

Ferrara N, Gerber HP, LeCouter J.

Nat Med. 2003 Jun;9(6):669-76. Review.

PMID:
12778165
4.
5.

Inhibition of vascular endothelial growth factor in the treatment of solid tumors.

Margolin K.

Curr Oncol Rep. 2002 Jan;4(1):20-8. Review.

PMID:
11734110
8.

Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

Ferrara N.

Am J Physiol Cell Physiol. 2001 Jun;280(6):C1358-66. Review.

9.

Angiogenesis in pituitary adenomas.

Yamada S, Takada K.

Microsc Res Tech. 2003 Feb 1;60(2):236-43. Review.

PMID:
12539178
10.

Emerging role of endothelin-1 in tumor angiogenesis.

Bagnato A, Spinella F.

Trends Endocrinol Metab. 2003 Jan;14(1):44-50. Review.

PMID:
12475611
11.

VEGF as a mediator of tumor-associated immunodeficiency.

Ohm JE, Carbone DP.

Immunol Res. 2001;23(2-3):263-72. Review.

PMID:
11444391
12.

[Neoplasms and angiogenesis].

Lewy-Trenda I.

Pol Merkur Lekarski. 2002 Sep;13(75):225-8. Review. Polish.

PMID:
12474576
13.

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.

Kerbel RS, Viloria-Petit A, Klement G, Rak J.

Eur J Cancer. 2000 Jun;36(10):1248-57. Review.

PMID:
10882863
14.

New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?

de Bont ES, Neefjes VM, Rosati S, Vellenga E, Kamps WA.

Leuk Lymphoma. 2002 Oct;43(10):1901-9. Review.

PMID:
12481883
16.

[Vascular endothelial growth factor (VEGF) and its role in neoplastic processes].

Loch T, Michalski B, Mazurek U, Graniczka M.

Postepy Hig Med Dosw. 2001;55(2):257-74. Review. Polish.

PMID:
11468973
17.

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Saaristo A, Karpanen T, Alitalo K.

Oncogene. 2000 Dec 11;19(53):6122-9. Review.

18.

Vascular endothelial growth factor gene regulation and action in diabetic retinopathy.

Lu M, Adamis AP.

Ophthalmol Clin North Am. 2002 Mar;15(1):69-79. Review.

PMID:
12064083
19.

Vascular endothelial growth factor as a target opportunity in hematological malignancies.

Bellamy WT.

Curr Opin Oncol. 2002 Nov;14(6):649-56. Review.

PMID:
12409656
20.

Pathological significance of vascular endothelial growth factor A isoform expression in human cancer.

Nakamura M, Abe Y, Tokunaga T.

Pathol Int. 2002 May-Jun;52(5-6):331-9. Review.

PMID:
12100515

Supplemental Content

Support Center